Provided by Tiger Trade Technology Pte. Ltd.

Amgen

391.27
-1.9000-0.48%
Pre-market: 389.20-2.0700-0.53%08:30 EDT
Volume:2.92M
Turnover:1.15B
Market Cap:210.69B
PE:24.30
High:395.55
Open:393.07
Low:389.28
Close:393.17
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.98
T/O Rate:0.54%
Dividend:9.80
Dividend Rate:2.50%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:18.03
PE(LYR):27.50

Loading ...

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS
·
Aug 27

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Aug 27

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 26

Political and General News Events from August 25

Reuters
·
Aug 25

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Aug 25

Political and General News Events from August 24

Reuters
·
Aug 24

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

TIPRANKS
·
Aug 22

Amgen is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 21

Amgen price target raised to $457 from $427 at Piper Sandler

TIPRANKS
·
Aug 20

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19